Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.78

0.0%

Dec 31 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (638)	1/18/2005 4:21:17 PM
From: Jibacoa	Read Replies (1) of 3722

AGEN still hasn't released the results from its PIII on Oncophage for renal cell Ca. In Oct. & Nov. the stock was having a nice uptrend after news that Garo Armen,its CEO, had purchased 100,000 shares and an investment newsletter made positive comments about the company and set a six-month price target at $20.<g> The stock traded at a H of $11.38 on Dec.6 but it dropped 24% on Dec.7 after it was downgraded by UBS analysts which also lowered their 12-month price target to $5.<g> The stock was able to close today above its Jan.13 H of $9.19 It was up more than 6% closing $0.05 below its intraday H of $9.58 bigcharts.marketwatch.com With good news on Oncophage's PIII the stock still could make that $20 target that was mentioned in Dec. But first it has to deal with its Dec.10 H of 11.30, its Jan.2004 H at 12.46, its Sep.2003 H at 15.70 and its Jun.2003 H at 16<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next